Elanco Animal Health (ELAN)

NYSE: ELAN · Real-Time Price · USD

9.47

-0.01 (-0.11%)

At close: May 01, 2025, 3:59 PM

9.44

-0.32%

Pre-market: May 02, 2025, 07:00 AM EDT

Elanco Animal Health Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Revenue	4.44B	4.45B	4.49B	4.37B	4.42B	4.37B	4.33B	4.45B	4.42B	4.54B	4.65B	4.75B	4.76B	4.79B	4.55B	3.86B	3.27B	2.92B	2.8B	3B	3.07B	3.08B	3.07B	3.06B	3.07B	3.02B	2.96B	2.91B	2.89B	2.13B	1.44B	718.8M
Cost of Revenue	2.4B	2.28B	2.14B	1.95B	1.93B	1.86B	1.85B	1.9B	1.91B	1.98B	2.01B	2.07B	2.13B	2.22B	2.16B	1.9B	1.67B	1.48B	1.4B	1.46B	1.47B	1.47B	1.48B	1.56B	1.57B	1.57B	1.57B	1.48B	1.47B	1.06B	686.2M	343.1M
Gross Profit	2.04B	2.17B	2.35B	2.41B	2.49B	2.51B	2.48B	2.55B	2.5B	2.57B	2.64B	2.67B	2.63B	2.57B	2.39B	1.95B	1.61B	1.44B	1.4B	1.54B	1.6B	1.61B	1.59B	1.5B	1.49B	1.46B	1.39B	1.42B	1.42B	1.07B	751.4M	375.7M
Operating Income	251M	219M	266M	204M	283M	313M	315M	397M	354M	282M	290M	275M	195M	154M	88.4M	-12.4M	-76.8M	102.5M	214.1M	301.5M	370M	388.2M	394.9M	325.1M	313.8M	253.6M	161.6M	187.65M	168.7M	138.4M	125.7M	62.85M
Interest Income	n/a	n/a	72M	146M	210M	272M	260M	186M	122M	60M	n/a	n/a	n/a	n/a	100K	100K	100K	100K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	488M	412M	-1.24B	-1.29B	-1.2B	-1.16B	-101M	-40M	-77M	-110M	-198M	-416M	-567M	-764.1M	-843.1M	-684.2M	-672M	-358.2M	-161.7M	-34.4M	78.2M	80.3M	171.6M	81.4M	114.1M	-39.1M	-127M	-121M	-232.5M	-77.1M	-68M	-34M
Net Income	338M	205M	-1.25B	-1.3B	-1.23B	-1.14B	-97M	-22M	-74M	-117M	-172M	-360M	-472M	-697.8M	-728.8M	-572M	-560.1M	-246.8M	-101.8M	-12.7M	67.9M	93.8M	144M	45.3M	86.5M	-91.4M	-172.3M	-173.75M	-310.7M	-149.2M	-128.5M	-64.25M
Selling & General & Admin	1.31B	1.31B	1.3B	1.29B	1.28B	1.3B	1.28B	1.27B	1.26B	1.29B	1.33B	1.38B	1.4B	1.45B	1.38B	1.16B	996.6M	808.4M	723M	761.1M	760.2M	759.4M	746.1M	736.3M	735.2M	746.9M	762.6M	765.7M	779.9M	583.1M	388.4M	194.2M
Research & Development	344M	342M	341M	333M	327M	328M	320M	321M	321M	333M	349M	361M	369M	389.7M	383.8M	349.2M	327M	281.6M	263.4M	272.8M	270.1M	263.9M	252.9M	245.5M	246.6M	247.5M	250.5M	253.05M	251.8M	189.8M	127.9M	63.95M
Other Expenses	-11M	-45M	-54M	-75M	68M	232M	369M	525M	528M	401M	262M	132M	142M	155.6M	281.5M	326.4M	178.3M	155.4M	25.9M	-25.9M	-27.4M	-46.8M	-45.7M	-50.6M	-49.9M	-24.2M	-8.8M	n/a	1.9M	1.9M	n/a	n/a
Operating Expenses	1.79B	1.92B	2.05B	2.17B	2.16B	2.16B	2.13B	2.12B	2.11B	2.16B	2.23B	2.28B	2.33B	2.42B	2.3B	1.97B	1.68B	1.34B	1.19B	1.24B	1.23B	1.22B	1.2B	1.18B	1.18B	1.2B	1.22B	1.33B	1.45B	1.13B	819.4M	409.7M
Interest Expense	235M	256M	270M	279M	277M	272M	260M	253M	241M	234M	234M	227M	236M	241.4M	229.5M	194.3M	149.8M	108.1M	78.7M	74.6M	78.9M	89.8M	79.7M	59M	38.2M	8.6M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	207M	207M	207M	207M	201M	201M	201M	201M	248M	248M	248M	248M	611M	611M	611M	793M	182M	182M	182M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	4.19B	4.2B	4.19B	4.13B	4.09B	4.03B	3.98B	4.01B	4.03B	4.14B	4.24B	4.36B	4.46B	4.64B	4.46B	3.87B	3.35B	2.82B	2.59B	2.7B	2.7B	2.7B	2.68B	2.74B	2.75B	2.77B	2.8B	2.82B	2.91B	2.19B	1.51B	752.8M
Income Tax Expense	150M	207M	11M	11M	36M	-12M	-4M	-18M	n/a	10M	-23M	-53M	-95M	-66.3M	-114.3M	-112.2M	-111.9M	-111.4M	-59.9M	-21.7M	10.3M	-13.5M	27.6M	36.1M	27.6M	52.3M	45.3M	52.75M	78.2M	72.1M	60.5M	30.25M
Shares Outstanding (Basic)	494.4M	494.3M	494.2M	493.2M	492.8M	492.7M	492.6M	491.1M	488.5M	488.4M	488.4M	488M	487.4M	487.3M	487.3M	486.7M	486.2M	462.4M	407.69M	403.9M	373M	371.6M	365.7M	365.7M	365.6M	365.6M	356.19M	356.2M	356.2M	365.6M	n/a	n/a
Shares Outstanding (Diluted)	494.4M	497.7M	494.2M	496M	492.8M	492.7M	492.6M	492.8M	488.5M	488.4M	488.4M	492.2M	487.4M	487.3M	487.3M	486.7M	486.2M	462.4M	413.2M	403.9M	374.8M	373.2M	367M	366M	365.6M	365.6M	356.19M	356.2M	365.6M	365.6M	n/a	n/a
EPS (Basic)	0.68	0.41	-2.55	-2.65	-2.5	-2.32	-0.2	-0.04	-0.15	-0.25	-0.35	-0.74	-0.97	-1.43	-1.51	-1.21	-1.2	-0.57	-0.25	-0.02	0.19	0.26	0.39	0.11	0.22	-0.27	-0.49	-0.31	-0.51	-0.06	n/a	n/a
EPS (Diluted)	0.67	0.40	-2.55	-2.65	-2.5	-2.32	-0.2	-0.04	-0.15	-0.25	-0.35	-0.74	-0.97	-1.43	-1.51	-1.21	-1.2	-0.57	-0.25	-0.02	0.19	0.26	0.39	0.11	0.22	-0.26	-0.48	-0.3	-0.5	-0.06	n/a	n/a
EBITDA	648M	600M	-247M	-212M	-117M	-82M	987M	1.06B	1.02B	987M	870M	859M	800M	651.3M	522.7M	248.9M	-19.5M	113M	318.3M	447.2M	563.4M	558.1M	558.8M	446M	461.3M	486.2M	396.7M	502.3M	487.1M	369.7M	281.8M	140.9M
EBIT	778M	723M	-919M	-957M	-918M	-881M	160M	218M	173M	136M	174M	-55M	-201M	-397.9M	-612.9M	-489.1M	-515.4M	-244.1M	14.9M	138M	248.9M	154.9M	144.3M	110.2M	126.4M	236.3M	161.6M	187.65M	168.7M	138.4M	125.7M	62.85M
Depreciation & Amortization	511M	669M	672M	687M	694M	692M	686M	680M	683M	688M	691M	690M	716M	764.2M	727.2M	637.2M	517.2M	378.4M	324.1M	321.3M	314.5M	281.2M	251.2M	249.3M	248.4M	285.4M	311.9M	314.65M	318.4M	231.3M	156.1M	78.05M